Global AI-Enabled Drug Discovery and Clinical Trials market predicted to propel by the application of AI which improves the speed and precision of discovery and reduce timelines for drug discovery
Global AI-Enabled Drug Discovery and Clinical Trials market estimated to grow with a noteworthy rate during the forecast period, 2020-2027. It is due to AI helping companies in calculating vast patient datasets into digestible, tangible information, identifying personalized, precision medicine opportunities, or potential forecasting responses to new drugs. Additionally, the growing applications of AI to analyze the pool of potential subjects in drug discovery, analyzing the electronic medical reports of patients, and genomic data for improved clinical trial matching will contribute to the growth of AI-enabled drug discovery and clinical trials market. Moreover, the surge in the application of AI in drug discovery benefits from the open-source implementation will augment the global AI-enabled drug discovery and clinical trial market in the future time.
AI help in accelerating the treatments of rare diseases, identify potential rare diseases indications and predicts new indications for existing medicines. Further, growing adoption of Ai in the pharmacy industry for target discovery, compound synthesis, compound screening, crystal form prediction, patient recruitment, optimization of clinical trial design, and drug redirection will boom the AI-enabled drug discovery and clinical trials in the near future.
Components Overview in the Global AI-Enabled Drug Discovery and Clinical Trials Market
Based on components, the global AI-enabled drug discovery and clinical Trials market bifurcated into Solutions and Services. The Solutions segment likely to lead the market by 2027, attributable to AI, help in substantial implications in the development of biomarkers and detect the differences between healthy and cancerous tissues.
Solution Overview in the Global AI-Enabled Drug Discovery and Clinical Trials market
Based on the Solution, the global AI-Enabled drug discovery and clinical trials market classified into Data Aggregation and Analysis, Clinical Trials, Drug Design, Drug Characterization, Biomarker Research, and Others. The Drug Design segment estimated to gain a higher market share by 2017. It is due to AI, and Machine learning helps to discover and develop new drugs for chronic kidney disease and idiopathic pulmonary fibrosis.
Application Overview in the Global AI-Enabled Drug Discovery and Clinical Trials Market
Based on application, the global AI-Enabled Drug Discovery and Clinical Trials market classified into Oncology, Cardiovascular Diseases, Nervous System Diseases, Respiratory Disorder, Metabolic Diseases Immunologic Diseases, Infectious Diseases, and Others. The Oncology segment projected to register a higher CAGR by 2027, on account of the surge in demand for AI for improving the quality of care and patient outcomes and improve the accuracy of cancer diseases while minimizing damage to healthy organs at risk.
End-User Overview in the Global AI-Enabled Drug Discovery and Clinical Trials Market
Based on end-user, the global AI-enabled drug discovery and clinical trials market categorized into Biopharmaceutical Industry, Contract Research Organizations (CROs), and Academic Institutes and Research Centers. Biopharmaceutical Industry projected to lead the market by 2027, as a result of AI and machine learning help in manufacturing process improvement, identifying novel biological target, processing biomedical and clinical data, and detect diseases such as cancer.
Regional Overview in the Global AI-Enabled Drug Discovery and Clinical Trials Market
By geography, the Global AI-Enabled Drug Discovery and Clinical Trials Market segmented into North America, Asia Pacific, Europe, Middle East & Africa, and South America. North America accounted for a major share in 2019 and expected to dominate the market by 2027 the market as a result of the high focus on R&D & substantial investment in the healthcare sector by USA governments and the presence of globally leading pharmaceutical companies.
Global AI-Enabled Drug Discovery and Clinical Trials Market: Competitive Landscape
Companies such as Accutar Biotechnology Inc., AiCure, LLC, Ardigen, Atomwise, Inc, BenevolentAI, Berg LLC, Berkeley Lights, Inc., Biovista Inc, BioAge Labs, Inc., C4X Discovery Holdings Plc, Clinithink Ltd, Cloud Pharmaceuticals, Inc., Cyclica, Inc., CytoReason, and Symphony Innovation, LLC are the key players in the Global AI-Enabled Drug Discovery and Clinical Trials Market.
Global AI-Enabled Drug Discovery and Clinical Trials Market Report Content 1. Research Strategic Development 1.1. Market Modelling 1.2. Product Analysis 1.3. Market Trend and Economic Factors Analysis 1.4. Market Segmental Analysis 1.5. Geographical Mapping 1.6. Country Wise Segregation 2. Research Methodology 2.1. Identification of Target Market 2.2. Data Acquisition 2.3. Refining of Data/ Data Transformations 2.4. Data Validation through Primary Techniques 2.5. Exploratory Data Analysis 2.6. Graphical Techniques/Analysis 2.7. Quantitative Techniques/Analysis 2.8. Visual Result/Presentation 3. Executive Summary 4. Market Insights 4.1. Economic Factor Analysis 4.1.1. Drivers 4.1.2. Trends 4.1.3. Opportunities 4.1.4. Challenges 4.2. Technological Landscape 4.3. Competitors & Product Analysis 4.4. Regulatory Framework 4.5. Company market share analysis, 2019 4.6. Porter's Five forces analysis 4.7. New Investment Analysis 4.8. PESTEL Analysis 5. Global AI-Enabled Drug Discovery and Clinical Trials Market Overview 5.1. Market Size & Forecast, 2016-2027 5.1.1. Demand 5.1.1.1. By Value (USD Million) 5.2. Market Share & Forecast, 2016-2027 5.2.1. By Component 5.2.1.1. Solutions 5.2.1.2. Services 5.2.2. By Solution 5.2.2.1. Data Aggregation and Analysis 5.2.2.2. Clinical Trials 5.2.2.3. Drug Design 5.2.2.4. Drug Characterization 5.2.2.5. Biomarker Research 5.2.2.6. Others 5.2.3. By Application 5.2.3.1. Oncology 5.2.3.2. Cardiovascular Diseases 5.2.3.3. Nervous System Diseases 5.2.3.4. Respiratory Disorder 5.2.3.5. Metabolic Diseases 5.2.3.6. Immunologic Diseases 5.2.3.7. Infectious Diseases 5.2.3.8. Others 5.2.4. By End-User 5.2.4.1. Biopharmaceutical Industry 5.2.4.2. Contract Research Organizations (CROs) 5.2.4.3. Academic Institutes and Research Centers 5.2.5. By Region 5.2.5.1. North America 5.2.5.2. Europe 5.2.5.3. Asia Pacific 5.2.5.4. South America 5.2.5.5. Middle East & Africa 6. North America AI-Enabled Drug Discovery and Clinical Trials Market Overview 6.1. North America AI-Enabled Drug Discovery and Clinical Trials Market Size & Forecast, 2016-2027 6.1.1. Demand 6.1.1.1. By Value (USD Million) 6.2. North America AI-Enabled Drug Discovery and Clinical Trials Market Share & Forecast, 2016-2027 6.2.1. By Component 6.2.1.1. Solutions 6.2.1.2. Services 6.2.2. By Solution 6.2.2.1. Data Aggregation and Analysis 6.2.2.2. Clinical Trials 6.2.2.3. Drug Design 6.2.2.4. Drug Characterization 6.2.2.5. Biomarker Research 6.2.2.6. Others 6.2.3. By Application 6.2.3.1. Oncology 6.2.3.2. Cardiovascular Diseases 6.2.3.3. Nervous System Diseases 6.2.3.4. Respiratory Disorder 6.2.3.5. Metabolic Diseases 6.2.3.6. Immunologic Diseases 6.2.3.7. Infectious Diseases 6.2.3.8. Others 6.2.4. By End-User 6.2.4.1. Biopharmaceutical Industry 6.2.4.2. Contract Research Organizations (CROs) 6.2.4.3. Academic Institutes and Research Centers 6.2.5. By Country 6.2.5.1. US 6.2.5.2. Canada 6.2.5.3. Mexico 6.2.6. Company Market Share (Top 3-5) 6.2.7. Economic Impact Study on North America AI-Enabled Drug Discovery and Clinical Trials Market 7. Europe AI-Enabled Drug Discovery and Clinical Trials Market Overview 7.1. Europe AI-Enabled Drug Discovery and Clinical Trials Market Size & Forecast, 2016-2027 7.1.1. Demand 7.1.1.1. By Value (USD Million) 7.2. Europe AI-Enabled Drug Discovery and Clinical Trials Market Share & Forecast, 2016-2027 7.2.1. By Component 7.2.1.1. Solutions 7.2.1.2. Services 7.2.2. By Solution 7.2.2.1. Data Aggregation and Analysis 7.2.2.2. Clinical Trials 7.2.2.3. Drug Design 7.2.2.4. Drug Characterization 7.2.2.5. Biomarker Research 7.2.2.6. Others 7.2.3. By Application 7.2.3.1. Oncology 7.2.3.2. Cardiovascular Diseases 7.2.3.3. Nervous System Diseases 7.2.3.4. Respiratory Disorder 7.2.3.5. Metabolic Diseases 7.2.3.6. Immunologic Diseases 7.2.3.7. Infectious Diseases 7.2.3.8. Others 7.2.4. By End-User 7.2.4.1. Biopharmaceutical Industry 7.2.4.2. Contract Research Organizations (CROs) 7.2.4.3. Academic Institutes and Research Centers 7.2.5. By Country 7.2.5.1. Germany 7.2.5.2. UK 7.2.5.3. France 7.2.5.4. Italy 7.2.5.5. Rest of Europe 7.2.6. Company Market Share (Top 3-5) 7.2.7. Economic Impact Study on Europe AI-Enabled Drug Discovery and Clinical Trials Market 8. Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Overview 8.1. Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Size & Forecast, 2016-2027 8.1.1. Demand 8.1.1.1. By Value (USD Million) 8.2. Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market Share & Forecast, 2016-2027 8.2.1. By Component 8.2.1.1. Solutions 8.2.1.2. Services 8.2.2. By Solution 8.2.2.1. Data Aggregation and Analysis 8.2.2.2. Clinical Trials 8.2.2.3. Drug Design 8.2.2.4. Drug Characterization 8.2.2.5. Biomarker Research 8.2.2.6. Others 8.2.3. By Application 8.2.3.1. Oncology 8.2.3.2. Cardiovascular Diseases 8.2.3.3. Nervous System Diseases 8.2.3.4. Respiratory Disorder 8.2.3.5. Metabolic Diseases 8.2.3.6. Immunologic Diseases 8.2.3.7. Infectious Diseases 8.2.3.8. Others 8.2.4. By End-User 8.2.4.1. Biopharmaceutical Industry 8.2.4.2. Contract Research Organizations (CROs) 8.2.4.3. Academic Institutes and Research Centers 8.2.5. By Country 8.2.5.1. China 8.2.5.2. India 8.2.5.3. Japan 8.2.5.4. Australia 8.2.5.5. Rest of Asia Pacific 8.2.6. Company Market Share (Top 3-5) 8.2.7. Economic Impact Study on Asia Pacific AI-Enabled Drug Discovery and Clinical Trials Market 9. South America AI-Enabled Drug Discovery and Clinical Trials Market Overview 9.1. South America AI-Enabled Drug Discovery and Clinical Trials Market Size & Forecast, 2016-2027 9.1.1. Demand 9.1.1.1. By Value (USD Million) 9.2. South America AI-Enabled Drug Discovery and Clinical Trials Market Share & Forecast, 2016-2027 9.2.1. By Component 9.2.1.1. Solutions 9.2.1.2. Services 9.2.2. By Solution 9.2.2.1. Data Aggregation and Analysis 9.2.2.2. Clinical Trials 9.2.2.3. Drug Design 9.2.2.4. Drug Characterization 9.2.2.5. Biomarker Research 9.2.2.6. Others 9.2.3. By Application 9.2.3.1. Oncology 9.2.3.2. Cardiovascular Diseases 9.2.3.3. Nervous System Diseases 9.2.3.4. Respiratory Disorder 9.2.3.5. Metabolic Diseases 9.2.3.6. Immunologic Diseases 9.2.3.7. Infectious Diseases 9.2.3.8. Others 9.2.4. By End-User 9.2.4.1. Biopharmaceutical Industry 9.2.4.2. Contract Research Organizations (CROs) 9.2.4.3. Academic Institutes and Research Centers 9.2.5. By Country 9.2.5.1. Brazil 9.2.5.2. Argentina 9.2.5.3. Rest of South America 9.2.6. Company Market Share (Top 3-5) 9.2.7. Economic Impact Study on South America AI-Enabled Drug Discovery and Clinical Trials Market 10. Middle East & Africa AI-Enabled Drug Discovery and Clinical Trials Market Overview 10.1. Middle East & Africa AI-Enabled Drug Discovery and Clinical Trials Market Size & Forecast, 2016-2027 10.1.1. Demand 10.1.1.1. By Value (USD Million) 10.2. Middle East & Africa AI-Enabled Drug Discovery and Clinical Trials Market Share & Forecast, 2016-2027 10.2.1. By Component 10.2.1.1. Solutions 10.2.1.2. Services 10.2.2. By Solution 10.2.2.1. Data Aggregation and Analysis 10.2.2.2. Clinical Trials 10.2.2.3. Drug Design 10.2.2.4. Drug Characterization 10.2.2.5. Biomarker Research 10.2.2.6. Others 10.2.3. By Application 10.2.3.1. Oncology 10.2.3.2. Cardiovascular Diseases 10.2.3.3. Nervous System Diseases 10.2.3.4. Respiratory Disorder 10.2.3.5. Metabolic Diseases 10.2.3.6. Immunologic Diseases 10.2.3.7. Infectious Diseases 10.2.3.8. Others 10.2.4. By End-User 10.2.4.1. Biopharmaceutical Industry 10.2.4.2. Contract Research Organizations (CROs) 10.2.4.3. Academic Institutes and Research Centers 10.2.5. By Country 10.2.5.1. Saudi Arabia 10.2.5.2. UAE 10.2.5.3. South Africa 10.2.5.4. Rest of Middle East & Africa 10.2.6. Company Market Share (Top 3-5) 10.2.7. Economic Impact Study on Middle East & Africa AI-Enabled Drug Discovery and Clinical Trials Market 11. Competitor Analysis 11.1. Company Description 11.2. Financial Analysis 11.3. Key Products 11.4. Key Management Personnel 11.5. Contact Address 11.6. SWOT Analysis 11.7. Company Profile 11.7.1. Accutar Biotechnology Inc. 11.7.2. AiCure, LLC 11.7.3. Ardigen 11.7.4. Atomwise, Inc 11.7.5. BenevolentAI 11.7.6. Berg LLC 11.7.7. Berkeley Lights, Inc. 11.7.8. BioAge Labs, Inc. 11.7.9. Biovista Inc 11.7.10. C4X Discovery Holdings Plc 11.7.11. Clinithink Ltd 11.7.12. Cloud Pharmaceuticals, Inc. 11.7.13. Cyclica, Inc. 11.7.14. CytoReason, 11.7.15. Symphony Innovation, LLC 11.7.16. Other Prominent Players
| Price : US$ 3500 | Date : Nov 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 160 |
| Price : US$ 3500 | Date : Nov 2024 |
| Category : Medical Devices | Pages : 121 |
| Price : US$ 3500 | Date : Nov 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 130 |
| Price : US$ 3500 | Date : Nov 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 119 |
| Price : US$ 3500 | Date : Nov 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 120 |
We will be happy to help you find what you need. Please call us or write to us:
Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).
This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection
Request Sample 
Request Discount 
Inquire Before Buy
